Michael E Prevoznik Quest Diagnostics Inc (DGX) insider trading activity

Michael E Prevoznik is SVP & General Counsel of QUEST DIAGNOSTICS INC. Currently has a direct ownership of 38,117 shares of DGX, which is worth approximately $5.23 Million. The most recent transaction as insider was on Mar 17, 2025, when has been sold 4,643 shares (Common Stock) at a price of $170.0 per share, resulting in proceeds of $789,310. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.1K

0.94% 3M change

0.94% 12M change

Total Value Held $5.23 Million

MICHAEL E PREVOZNIK Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 17 2025	SELL Open market or private sale	$789,310 $170.0 p/Share	4,643 Reduced 10.86%	38,117 Common Stock
Mar 04 2025	SELL Open market or private sale	$104,067 $175.79 p/Share	592 Reduced 1.53%	38,117 Common Stock
Mar 04 2025	SELL Payment of exercise price or tax liability	$678,628 $173.74 p/Share	3,906 Reduced 8.37%	42,760 Common Stock
Mar 04 2025	BUY Grant, award, or other acquisition	$1,485,303 $173.74 p/Share	8,549 Added 15.48%	46,666 Common Stock
Mar 03 2025	SELL Payment of exercise price or tax liability	$55,944 $173.74 p/Share	322 Reduced 0.82%	38,709 Common Stock
Feb 27 2025	SELL Open market or private sale	$91,138 $172.61 p/Share	528 Reduced 1.33%	39,031 Common Stock
Feb 26 2025	SELL Payment of exercise price or tax liability	$49,120 $171.75 p/Share	286 Reduced 0.72%	39,559 Common Stock
Feb 20 2025	SELL Open market or private sale	$103,277 $170.99 p/Share	604 Reduced 1.49%	39,845 Common Stock
Feb 19 2025	SELL Payment of exercise price or tax liability	$63,471 $169.71 p/Share	374 Reduced 0.92%	40,449 Common Stock
Feb 12 2025	BUY Grant, award, or other acquisition	-	2,345 Added 5.43%	40,823 Common Stock
Nov 29 2024	SELL Open market or private sale	$5,718,254 $162.7 p/Share	35,146 Reduced 47.74%	38,478 Common Stock
Nov 29 2024	BUY Exercise of conversion of derivative security	$3,044,697 $86.63 p/Share	35,146 Added 32.31%	73,624 Common Stock
Aug 29 2024	SELL Open market or private sale	$5,044,428 $154.97 p/Share	32,551 Reduced 45.83%	38,478 Common Stock
Aug 29 2024	BUY Exercise of conversion of derivative security	$3,118,385 $95.8 p/Share	32,551 Added 31.43%	71,029 Common Stock
Feb 29 2024	SELL Open market or private sale	$706,312 $125.88 p/Share	5,611 Reduced 12.73%	38,478 Common Stock
Feb 28 2024	SELL Payment of exercise price or tax liability	$108,795 $126.36 p/Share	861 Reduced 1.92%	44,089 Common Stock
Feb 23 2024	SELL Payment of exercise price or tax liability	$353,181 $125.02 p/Share	2,825 Reduced 5.91%	44,950 Common Stock
Feb 23 2024	BUY Grant, award, or other acquisition	$946,276 $125.02 p/Share	7,569 Added 13.68%	47,775 Common Stock
Feb 22 2024	SELL Open market or private sale	$83,378 $126.14 p/Share	661 Reduced 1.62%	40,206 Common Stock
Feb 21 2024	SELL Payment of exercise price or tax liability	$50,883 $125.02 p/Share	407 Reduced 0.99%	40,867 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	2,935 Added 6.64%	41,274 Common Stock
Mar 07 2023	SELL Open market or private sale	$668,174 $140.55 p/Share	4,754 Reduced 10.98%	38,527 Common Stock
Mar 06 2023	SELL Payment of exercise price or tax liability	$567,930 $147.86 p/Share	3,841 Reduced 8.15%	43,281 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	$1,270,856 $147.86 p/Share	8,595 Added 15.43%	47,122 Common Stock
Mar 02 2023	SELL Open market or private sale	$82,154 $138.54 p/Share	593 Reduced 1.52%	38,527 Common Stock

MEP

Michael E Prevoznik

SVP & General Counsel

Secaucus, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DGX shares.

Notify only if

Value

Insider Trading

Get notified when an Quest Diagnostics Inc insider buys or sells DGX shares.

Notify only if

Operation

Value

Type

News

Receive news related to QUEST DIAGNOSTICS INC

Track Activities on DGX

Account